Precision Dosing in Neurological Care

Effective Epilepsy Medication Monitoring is essential for patient safety. Therefore, the All India Institute of Medical Sciences (AIIMS) in New Delhi has introduced a specialized facility for monitoring anti-epilepsy drug levels. Specifically, the service tracks levetiracetam and lamotrigine in the blood. Doctors explain that the same dose affects patients differently due to unique metabolic rates. Consequently, inaccurate drug levels can lead to seizure recurrence or medication toxicity.

Benefits of Epilepsy Medication Monitoring

Personalizing treatment through monitoring offers several advantages for clinicians and patients alike. First, it ensures that drug concentrations remain within the therapeutic window. Second, it helps identify toxicity risks before they cause severe side effects. Furthermore, the test detects cases where medicines fail to reach effective levels despite regular intake. Because private laboratories charge between Rs 6,000 and Rs 10,000 per drug, this low-cost initiative significantly improves access to precision-based care.

Expanding Access to Advanced Diagnostics

The new facility is located at the AIIMS Neurosciences Centre and extends services to the NCI-AIIMS Jhajjar campus. Currently, patients can access these tests free of cost, though subsidized rates may apply later. Additionally, results are available online through the e-Hospital and ORS portals. This digital integration ensures that both outpatient and admitted patients receive timely data. Moreover, advanced neurodiagnostic facilities like these help manage complex neurological disorders more effectively.

Frequently Asked Questions

Q1: Which specific medications does the new AIIMS TDM facility monitor?

The facility currently monitors levels of two common anti-epilepsy drugs, levetiracetam and lamotrigine, to ensure they are at safe and effective levels.

Q2: How much do these TDM tests cost at AIIMS?

The tests are currently provided free of charge at AIIMS. However, the institute may introduce highly subsidized rates in the future as per their policy.

Q3: Is the monitoring service available for both outpatients and admitted patients?

Yes, the facility serves both outpatients (OPD) and admitted patients at AIIMS New Delhi and the NCI-AIIMS Jhajjar campus.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer - ETHealthworld


2. Patsalos PN, et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies.


3. Epilepsy Society. Therapeutic Drug Monitoring (TDM) for Anti-Seizure Medications.